American University of Beirut

Decode the genetics. Enhance the treatment.

Every patient reacts differently to illness and treatment, making personalized care essential. The Pharmacogenomics Online Certificate at the American University of Beirut (AUB) empowers healthcare professionals to integrate genetic insights into pharmaceutical decision-making. Designed for those committed to advancing precision medicine, this program provides the skills needed to optimize patient care, develop tailored treatments, and lead pharmacogenomics initiatives both regionally and globally.

​​​​​​​Lead the way in precision medicine with our Pharmacogenomics Online Certificate.​

 

Who should enroll?

​This program is designed for healthcare professionals and institutions committed to advancing their expertise and leading the charge in medical innovation. It is particularly suited for:

  • Fresh graduates
  • Early-career healthcare professionals
  • Pharmacists
  • Lab technologists
  • Biomedical researchers
  • Healthcare professionals of all backgrounds
  • Medical Centers and Hospitals
  • Laboratories
  • Healthcare Systems
  • Pharmaceutical Companies
  • Academic Institutions 

Learning journey

The certificate comprises seven weeks of immersive learning, covering foundational concepts, clinical applications, and advanced strategies in pharmacogenomics. Delivered 100% online, it provides a flexible and dynamic learning experience suitable for busy professionals. Our program offers 11 modules worth 3 credits in total: 

​​Module
Skills AcquiredDemand
Module 1: What is pharmacogenomics: history, definitions, basic principles and concepts

Grasp basic principles and concepts, history, and relevant definitions.  ​

Growing demand among healthcare practitioners
Module 2: Pharmacogenomic resources and evidence

Understand key resources and clinical guidelines

High among medical and pharmacy professionals

Module 3: Pharmacogenomics of phase 1 CYP450 enzymes

Gain detailed knowledge of phase 1 enzymes affecting drug metabolism

High among pharmacists and clinicians

Module 4: Pharmacogenomics of phase 2 enzymes

Understand the role of phase 2 enzymes in drug metabolism, their genetic variations, and their impact on drug efficacy and toxicity.

High demand among pharmacologists and clinicians specializing in personalized medicine and medication safety.

Module 5: Pharmacogenomics of drug transporters and targets

Learn about drug transporters and molecular targets, their genetic variability, and their effect on drug absorption, distribution, and elimination.

Increasing demand among clinical pharmacologists, researchers, and drug development specialists.
Module 6: Pharmacogenomic applications in cancer​

Learn how pharmacogenomics is applied in oncology, including biomarker-driven therapies and genetic testing for cancer treatment

High demand due to the growing emphasis on precision oncology and targeted cancer therapies.
Module 7: Pharmacogenomic applications in cardiology

Delve into the application of pharmacogenomics in cardiovascular treatments

Increasing demand for specialized knowledge in cardiology

Module 8: Ethnicity considerations in pharmacogenomics Analyze how genetic diversity across different ethnic groups influences drug response and pharmacogenomic guidelines.

Growing need for culturally competent healthcare professionals and researchers in global pharmacogenomics.

Module 9: Genotyping strategies and methods in pharmacogenomics

Learn techniques for genotyping and interpreting genetic tests

High demand due to the growth of genetic testing services ​

Module 10: Implementation of pharmacogenomics into clinical practice

Gain practical skills for applying pharmacogenomics in clinical settings

High demand for hands-on clinical applications

Module 11: Considerations for moving forward in pharmacogenomics: challenges and programs Identify challenges in implementing pharmacogenomics, evaluate global initiatives, and propose solutions for integration into healthcare systems.

Increasing need for healthcare policymakers, researchers, and industry leaders in pharmacogenomics implementation.​

Learning outcomes

Graduates will master skills essential for advancing pharmacogenomics in clinical and research settings, they will be able to:

  • Explain how gene variants can affect the pharmacokinetics and/or pharmacodynamics of drugs 
  • Identify the genetic basis of variability in drug response and how it contributes to drug efficacy and toxicity. 
  • Find pharmacogenomic information from various sources. 
  • Explain the levels of evidence in pharmacogenomic literature and guidelines. 
  • Evaluate drug-specific pharmacogenomic clinical and prescription guidelines. 
  • Realize the role of ethnicity on applying pharmacogenomic algorithms. 
  • Differentiate genotyping methods, platforms and strategies used for pharmacogenomic testing. 
  • Explain pharmacogenomic test results and reports.

Unique features

  • Recognized Certification: Take the next step in your career, positioning you as a leader in advancing personalized drug therapy. 
  • Flexible Online Learning: Study at your own pace with interactive modules.
  • Expert Faculty: Learn from a regionally leading research program in pharmacogenomics.
  • Practical Case Studies: Engage with real-world scenarios to enhance decision-making.
  • Networking Opportunities: Connect with experts and peers in personalized medicine. 


    Admission requirements

    ​Ideally candidates must hold a bachelor's degree in a healthcare or biomedical related field such as:

    • Biomedical Sciences
    •  Pharmacy
    •  Nursing
    •  Public Health
    •  Medicine 

    Candidates must also meet AUB's English proficiency requirements. 

    Tuition & Fees

    • ​Total program tuition: $1,350 USD
    • Payments can only be made in USD.
    • Online payments are accepted.
    • Benefit from a 10% early bird discount by paying in full before the start date.
    • AUB graduates and staff can receive a 15% discount.
    • Corporate tuition rates are also available.

    Contact Information

    ​For additional information or to enroll your team, contact:

    Mr. Ribal Hmaidane, Program Manager Email: rh255@aub.edu.lb | Phone: +961 1 35 00 00 Ext. 4714 ​​

    Meet the Expert

     

    N​athalie Khoueiry Zgheib, MD.

    Dr. Nathalie Khoueiry Zgheib is a Tenured Professor in the Department of Pharmacology and Toxicology at the American University of Beirut Faculty of Medicine (AUBFM). She earned her medical degree from AUB and subsequently specialized in Clinical Pharmacology at the University of Pittsburgh. Dr. Zgheib is also a trained Family Physician, bringing a comprehensive perspective to her medical and research endeavors.

    In 2007, Dr. Zgheib established and has since directed the Pharmacogenetics Laboratory at AUBFM. Her research primarily focuses on the pharmacogenetics and pharmacoepigenetics of non-communicable diseases, with a particular emphasis on cancer and cardiovascular conditions. Her work involves investigating genetic polymorphisms related to drug-metabolizing enzymes and transporters, aiming to understand their impact on treatment outcomes for various cancers, including childhood leukemias, breast cancer, and bladder cancer. Initially adopting a candidate gene approach, her research has evolved to incorporate high-throughput analyses, extensive genotyping, and the development of research registries for comprehensive patient follow-up. Dr. Zgheib has also been leading a series of scholarly efforts in knowledge translation with the aim to better understand the distinct challenges and opportunities for the clinical implementation of pharmacogenomics in the MENA region. Her laboratory is also engaged in toxicology projects exploring the mechanisms by which environmental toxins contribute to cancer development.

    Dr. Zgheib's dedication to advancing pharmacogenomics and personalized medicine has been recognized through various grants and awards. Notably, in 2020, she received the prestigious Abdul Hameed Shoman Award for Arab Researchers in Pharmacogenetics. Her laboratory's research is supported by both intramural and extramural funding, enabling projects that delve into the genetic and epigenetic factors influencing drug response and disease susceptibility.

    Throughout her career, Dr. Zgheib has authored numerous publications, contributing significantly to the fields of pharmacogenomics, toxicology, and medical education. Her work is widely cited, underscoring her influence and the impact of her research on the scientific community. Dr. Zgheib's multifaceted expertise and unwavering commitment to research and education continue to advance the understanding of pharmacogenomics and its application in personalized medicine, ultimately aiming to improve patient care and treatment outcomes.​

    Contact Us

    For various questions, please try contacting us via social media first!
    read more

    Privacy Statement

    We take data privacy seriously and adhere to all applicable data privacy laws and regulations.
    read more

    Copyright and Disclaimer

    Written permission is needed to copy or disseminate all or part of the materials on the AUB website.
    read more

    Title IX, Non-Discrimination, and Anti-Discriminatory Harassment

    AUB is committed to providing a safe and respectful environment to all members of its community.
    read more